The authors describe considerations and best practices for meeting drug substance uniformity.
Eric Rydholm
Advertisement
Articles by Eric Rydholm
Advertisement
Latest Updated Articles
Practical Considerations for Demonstrating Drug Substance UniformityPublished: April 1st 2011 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
2
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
3
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
4
Everything to Know About Cell and Gene Therapy in 2025
5
